Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01227135
What this trial is testing

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Lynn McMahon 66
Early research (Phase 1)Study completedNCT00077558
What this trial is testing

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01819558
What this trial is testing

Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome
Institut Paoli-Calmettes 2
Not applicableStudy completedNCT04965649
What this trial is testing

Is There an Association Between Innate CD8+ T Cells and the Evolution of Tyrosine Kinase Inhibitor Resistance Mutations in Phi+ Hematological Malignancies.

Who this might be right for
LeukemiaMyelogenous LeukemiaChronic Leukemia+1 more
Centre Hospitalier Universitaire de Nīmes 30
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Early research (Phase 1)Ended earlyNCT02782403
What this trial is testing

Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia (CML)Blast Phase Chronic Myelogenous Leukemia (CML)Chronic Phase Phase Chronic Myelogenous Leukemia (CML)+1 more
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT06945146
What this trial is testing

Genomics Study in CML Patients With Ponatinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Dong-Wook Kim 65
Not applicableStudy completedNCT06692803
What this trial is testing

Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 2,043
Testing effectiveness (Phase 2)Study completedNCT03625388
What this trial is testing

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hikma Pharmaceuticals LLC 56
Testing effectiveness (Phase 2)Study completedNCT02896842
What this trial is testing

A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Versailles Hospital 139
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Large-scale testing (Phase 3)Ended earlyNCT02115386
What this trial is testing

Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
Novartis Pharmaceuticals 7
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Not applicableUnknownNCT03933852
What this trial is testing

Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
University of Jena 100
Not applicableUnknownNCT01562847
What this trial is testing

Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib

Who this might be right for
Chronic Myeloid Leukemia
Seoul St. Mary's Hospital 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147612
What this trial is testing

Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia With BCR-ABL1+3 more
M.D. Anderson Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Early research (Phase 1)Study completedNCT01751919
What this trial is testing

A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I)

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
Dong-A ST Co., Ltd. 37
Not applicableUnknownNCT02883036
What this trial is testing

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Nanfang Hospital, Southern Medical University 100
Early research (Phase 1)Study completedNCT01270984
What this trial is testing

Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects

Who this might be right for
Chronic Myeloid LeukemiaGastrointestinal Stromal Tumors
Chong Kun Dang Pharmaceutical 30
Next Page